Skip to main content
See every side of every news story
Published loading...Updated

What to Know About This $345,000 Enliven Insider Sale as the Stock Soars 130%

Summary by The Motley Fool
Key PointsA director of Enliven Therapeutics reported selling 10,000 shares in open-market transactions on June 5, 2026, for a total value of $345,000.The sale represented 16.16% of Lori Anne Kunkel’s direct common stock holdings, reducing her position from 61,884 to 51,884 shares.All shares involved were held directly; there was no indirect ownership or derivative security activity.10 stocks we like better than Enliven Therapeutics › Lori Anne …

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Saturday, June 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal